These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27649548)

  • 61. New small-molecule inhibitors of dihydrofolate reductase inhibit Streptococcus mutans.
    Zhang Q; Nguyen T; McMichael M; Velu SE; Zou J; Zhou X; Wu H
    Int J Antimicrob Agents; 2015 Aug; 46(2):174-82. PubMed ID: 26022931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protein flexibility and species specificity in structure-based drug discovery: dihydrofolate reductase as a test system.
    Bowman AL; Lerner MG; Carlson HA
    J Am Chem Soc; 2007 Mar; 129(12):3634-40. PubMed ID: 17335207
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Calorimetric studies of ligand binding in R67 dihydrofolate reductase.
    Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE
    Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Theory and application of molecular potential energy fields in molecular shape analysis: a quantitative structure--activity relationship study of 2,4-diamino-5-benzylpyrimidines as dihydrofolate reductase inhibitors.
    Hopfinger AJ
    J Med Chem; 1983 Jul; 26(7):990-6. PubMed ID: 6345782
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
    Otzen T; Wempe EG; Kunz B; Bartels R; Lehwark-Yvetot G; Hänsel W; Schaper KJ; Seydel JK
    J Med Chem; 2004 Jan; 47(1):240-53. PubMed ID: 14695838
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prediction of residues involved in inhibitor specificity in the dihydrofolate reductase family.
    Goodey NM; Herbert KG; Hall SM; Bagley KC
    Biochim Biophys Acta; 2011 Dec; 1814(12):1870-9. PubMed ID: 21840427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase.
    Debnath AK
    J Med Chem; 2002 Jan; 45(1):41-53. PubMed ID: 11754578
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
    Thakkar SS; Thakor P; Ray A; Doshi H; Thakkar VR
    Bioorg Med Chem; 2017 Oct; 25(20):5396-5406. PubMed ID: 28789907
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.
    Yang X; Wedajo W; Yamada Y; Dahlroth SL; Neo JJ; Dick T; Chui WK
    Eur J Med Chem; 2018 Jan; 144():262-276. PubMed ID: 29274493
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1).
    Gangjee A; Jain HD; Phan J; Lin X; Song X; McGuire JJ; Kisliuk RL
    J Med Chem; 2006 Feb; 49(3):1055-65. PubMed ID: 16451071
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview.
    Periti P
    J Chemother; 1995 Jun; 7(3):221-3. PubMed ID: 7562018
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with omega-carboxyalkoxy or omega-carboxy-1-alkynyl substitution in the side chain.
    Chan DC; Fu H; Forsch RA; Queener SF; Rosowsky A
    J Med Chem; 2005 Jun; 48(13):4420-31. PubMed ID: 15974594
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triazine-benzimidazole hybrids: anticancer activity, DNA interaction and dihydrofolate reductase inhibitors.
    Singla P; Luxami V; Paul K
    Bioorg Med Chem; 2015 Apr; 23(8):1691-700. PubMed ID: 25792141
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.
    Bourne CR; Wakeham N; Nammalwar B; Tseitin V; Bourne PC; Barrow EW; Mylvaganam S; Ramnarayan K; Bunce RA; Berlin KD; Barrow WW
    Biochim Biophys Acta; 2013 Jan; 1834(1):46-52. PubMed ID: 22999981
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Halogenated derivatives of methotrexate as human dihydrofolate reductase inhibitors in cancer chemotherapy.
    Uddin N; Ahmed S; Khan AM; Mazharol Hoque M; Halim MA
    J Biomol Struct Dyn; 2020 Feb; 38(3):901-917. PubMed ID: 30938661
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer.
    Singh A; Deshpande N; Pramanik N; Jhunjhunwala S; Rangarajan A; Atreya HS
    Sci Rep; 2018 Feb; 8(1):3190. PubMed ID: 29453377
    [TBL] [Abstract][Full Text] [Related]  

  • 78. On the interpretation and interpretability of quantitative structure-activity relationship models.
    Guha R
    J Comput Aided Mol Des; 2008 Dec; 22(12):857-71. PubMed ID: 18784976
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Applications of Receptor- and Ligand-based Models in Inverse Docking Experiments: Recognition of Dihydrofolate Reductase Using 7,8-Dialkyl- 1,3-Diaminopyrrolo[3,2-f]Quinazolines.
    Kumar SP; Jasrai YT; Pandya HA
    Curr Comput Aided Drug Des; 2016; 12(1):15-28. PubMed ID: 26725591
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dihydrofolate reductase: binding of substrates and inhibitors and catalytic mechanism.
    Gready JE
    Adv Pharmacol Chemother; 1980; 17():37-102. PubMed ID: 7004143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.